| Literature DB >> 35527279 |
Daniel Aiham Ghazali1,2,3, Philippe Kenway4, Christophe Choquet4, Enrique Casalino4,5.
Abstract
BACKGROUND: Elderly and frail patients who are unable to call for help in case of vital distress can develop complications during their hospitalization. As a supplement to clinical monitoring by the nursing staff, these patients can also be monitored in real time, with the Sensium E-health technology. An application notifies clinical staff of any change in their vital signs (heart rate, respiratory rate, temperature) outside of normal ranges, suggestive of physiological decline. Nurses and physicians are notified of these abnormal changes by email and also via mobile application (iPhone or iPad), allowing early intervention to prevent further deterioration. CASEEntities:
Keywords: E-health; Emergency medicine; Intensive care unit; Older patient; Sepsis
Mesh:
Year: 2022 PMID: 35527279 PMCID: PMC9082870 DOI: 10.1186/s13256-022-03385-9
Source DB: PubMed Journal: J Med Case Rep ISSN: 1752-1947
Initial blood sample in the emergency department
| Examination | Result | Unit | Usual value | Interpretation |
|---|---|---|---|---|
| Blood chemistry tests | ||||
| Glucose | 8.4 | mmol/L | 4.1–5.9 | Above high normal |
| Sodium | 137 | mmol/L | 135–145 | Normal |
| Potassium | 4.4 | mmol/L | 3.5–5 | Normal |
| Chlorine | 98 | mmol/L | 98–108 | Normal |
| Bicarbonate | 27 | mmol/L | 24–32 | Normal |
| Calcium | 2.58 | mmol/L | 2.18–2.6 | Normal |
| Phosphorus | 1.38 | mmol/L | 0.78–1.45 | Normal |
| Anion gap | 16 | mmol/L | – | |
| Plasma proteins | 74 | g/L | 57–82 | Normal |
| Creatinine | 139 | µmol/L | 44–71 | Above high normal |
| Urea | 8.7 | mmol/L | 3.2–8.2 | Above high normal |
| Creatinine clearance (MDRD equation) | 33 | mL/min | > 90 | Below low normal |
| Aspartate aminotransferase (AST) | 96 | U/L | 13–40 | Above high normal |
| Alanine aminotransferase (ALT) | 122 | U/L | < 40 | Above high normal |
| Total bilirubin | 42 | µmol/L | 5–21 | Above high normal |
| Indirect bilirubin | 21 | µmol/L | < 18 | Above high normal |
| Alkaline phosphatase | 217 | U/L | 46–116 | Above high normal |
| Gamma-glutamyl transferase | 203 | U/L | < 38 | Above high normal |
| Lipase | 24 | U/L | 12–53 | Normal |
| CRP (C-reactive protein) | 199.4 | mg/L | < 5 | Above high normal |
| Procalcitonin | 0.56 | µg/L | ||
| Complete blood count (CBC) | ||||
| White blood cells | 24.0 | 103/mm3 | 4–10 | Above high normal |
| Red blood cells | 4.43 | 106/mm3 | 3.8–5.2 | Normal |
| Hemoglobin | 14.9 | g/dL | 11.5–16 | Normal |
| Hematocrit | 40.8 | % | 35–45 | Normal |
| Mean blood volume | 92.1 | µL3 | 80–100 | Normal |
| Mean blood content | 30.0 | pg | 27–32 | Normal |
| Blood Hb concentration | 32.6 | % | 32–36.5 | Normal |
| Platelets | 195 | 103/mm3 | 150–400 | Normal |
| Formula: neutrophils | 90.1%, 21.6 × 103/mm3 | – | – | |
| Formula: eosinophilic polynuclears | 0.0%, 0.0 × 103/mm3 | – | – | |
| Formula: basophilic polynuclears | 0.2%, 0.0 × 103/mm3 | – | – | |
| Formula: lymphocytes | 3.8%, 0.9 × 103/mm3 | – | – | |
| Formula: monocytes | 5.9%, 1.4 × 103/mm3 | – | – | |
| Blood clotting tests | ||||
| PT: control | 11.7 | Seconds | – | |
| PT: patient | 13.1 | Seconds | – | |
| PT: prothrombin rate | 80 | % | 70–100 | Normal |
| INR | 1.11 | – | – | |
| aPTT (control) | 24.4 | Seconds | – | |
| aPTT (sick) | 23.6 | Seconds | – | |
| aPTT (ratio) | 0.97 | Null | ≤ 1.2 | Normal |
| Arterial blood gas | ||||
| pH | 7.426 | Null | 7.38–7.42 | Above high normal |
| PaO2 | 76.0 | mmHg | 80–100 | Below low normal |
| PaCO2 | 39.2 | mmHg | 38–42 | Normal |
| HCO3 | 26.5 | mmol/L | 21–28 | Normal |
| Base excess/deficit | 1.4 | mmol/L | – | |
| SaO2 | 94.0 | % | 95–99 | Below low normal |
| Arterial lactates | 1.90 | mmol/L | < 1.6 | Above high normal |
PT prothrombin, INR International Normalized Ratio, aPTT Activated Partial Thromboplastin Time, pH potential of hydrogen, SaO2 oxygen saturation, PaO2 partial pressure of oxygen, PaCO2 partial pressure of carbon dioxide, HCO3 Concentration of hydrogen carbonate, Hb Hemoglobin, MDRD Modification of Diet in Renal Disease
Fig. 1Clinical early warning system. A Wireless monitoring system. B Sensium application for continuous monitoring of vital signs. C Software with analysis of vital signs. D iPad fixed on the nurse trolley for continuous monitoring of vital signs
Fig. 2Early diagnosis of severe sepsis using Sensium E-health technology. A Wireless monitoring system with analysis of vital signs. B Extrapolated curves; HR, heart rate; RR, respiration rate; Temp, temperature
Fig. 3Multiple foci of nephritis of the upper pole of the right kidney. Axial CT slice through the abdomen from CT scans without injection of intravenous contrast (photo 1), CT Scout view (photo 2), and with injection of intravenous contrast (photos 3 and 4). B, back; Bo, bottom; F, front; L, left; R, right; T, top. CT scan found multiple triangular hypodensities (indicated by the red arrows) of the right superior polar renal cortex in favor of foci of nephritis. Absence of contrast of the right pyelic walls. There was no dilatation of the right and left pyelocaliceal cavities. There was no parenchymal abnormality of the left renal pelvis. The bladder was in low replenishment. There was no evidence of lithiasis in the urinary excretory tract. There was no abnormality in the hepatic, splenic, pancreatic, or adrenal compartments. No intraperitoneal or retroperitoneal effusion was observed. There was a good permeability of the vascular axes. Conclusion: multiple foci of nephritis of the upper pole of the right kidney; no dilatation of the pyelocaliceal cavities or obstruction of the urinary excretory tract
Urine culture and antimicrobial susceptibility test results
| Examination | Result | Unit | Usual value |
|---|---|---|---|
| Direct examination | |||
| Number of red blood cells | 6 | 103/mL | ≤ 10.103/mL |
| Number of leukocytes | 126 | 103/mL | ≤ 10.103/mL |
| Semi-quantitative cytology | |||
| Epithelial cells | Some | ||
| Oxalate crystals | Some | ||
| Culture | |||
| Bacterial species: | 106 | CFU/mL | |
Antibiotic susceptibility testing | |||
| Bacterial species: | |||
| Ampicillin | R | ||
| Amoxicillin + clavulanic acid | R | ||
| Ticarcillin | R | ||
| Piperacillin + tazobactam | S | ||
| Mecillinam | S | ||
| Cefoxitine | S | ||
| Cefixime | S | ||
| Ceftazidim | S | ||
| Ceftriaxone | S | ||
| Amikacin | S | ||
| Gentamicin | S | ||
| Ofloxacin | S | ||
| Fosfomycin | S | ||
| Nitrofurantoin | S | ||
| Trimethoprim + sulfonamides | S | ||
R resistance, S sensitivity